LMN-201 for Prevention of C. Difficile Infection Recurrence

Condition:   Clostridioides Difficile Infection Interventions:   Drug: LMN-201;   Drug: Placebo Sponsor:   Lumen Bioscience, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials